GreenSky President’s Club invests $350k in Mirexus Biotechnologies
Mirexus Biotechnologies Inc, which is commercializing technology based on polysaccharide sub-micron particles that can be used in various industry applications, has secured $350,000 in seed financing. The company's backers are members of GreenSky President’s Club (GPC) and other angel investors. Funding proceeds will allow the Guelph, Ontario-based Mirexus to pursue target markets in personal care and nutraceuticals and continue R&D on applications for these and healthcare sectors. GPC was launched in November 2013 by Toronto-based corporate finance advisory firm GreenSky Capital. GPC deal opportunities are sourced, vetted and managed by GreenSky.
13 March 2014•2 mins read
